Novo Nordisk faces a shareholder backlash on Friday as the Danish drugmaker's minority investors prepare a protest vote ...
Newly-elected chairman of Wegovy-maker Novo Nordisk , Lars Rebien Sorensen, said on Friday he plans to enhance the board's ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — Novo Nordisk, under new leadership and in need of a boost, said ...
The executive, who brought Novo’s first weight-loss shot to market, had to spend part of the meeting explaining why proposed ...
10don MSN
Pfizer adquiere Metsea, desarrolladora de fármacos contra la obesidad, tras puja con Novo Nordisk
El gigante farmacéutico estadounidense Pfizer firmó un acuerdo para adquirir Metsera Inc., la empresa desarrolladora de ...
Mike Doustdar, new CEO of Ozempic maker, Novo Nordisk discusses his strategy for the future of the company. Trump demands ...
Novo Nordisk, the 102-year-old Danish drugmaker behind the blockbuster drugs Ozempic and Wegovy, is laying off thousands of workers as it seeks to recoup some of the revenue it’s lost to competitors ...
Novo Nordisk is set to lay off roughly 9,000 employees across its global workforce of 78,400 as part of a newly launched restructuring initiative. In a Sept. 10 press release, the Danish ...
As obesity pioneer Novo Nordisk loses ground in the race for next-generation drugs, the Danish pharma giant is betting on novel RNA technology to bolster its early-stage pipeline. Novo has inked a ...
The entrance to one of Novo Nordisk’s two manufacturing facilities in Clayton, North Carolina on June 24, 2024. Brian Gordon [email protected] The Danish drugmaker Novo Nordisk announced ...
Novo Nordisk has been on a rollercoaster this year, with stiff competition in the weight-loss drugs space. Ahead of their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback